DE | EN | ES


HAPILA is engaged in three major business areas of the API value-creation chain: synthesis, purification and particle design; this makes HAPILA a highly efficient bridge-builder between production of the API and its suitability for pharmaceutical production.

The business field synthesis at a glance.

Optimisation of established chemicals syntheses of active pharmaceutical ingredients
Development of synthesis processes
Manufacturing of active pharmaceutical ingredients under GMP conditions
Manufacturing of reference standard substances

Scale: laboratory (1 g)  - pilot (100 g) - production (10 kg)
: regulatorily relevant documents, GMP certified